The Global Biotechnology industry comprises a diverse range of firms engaged in the development of pharmaceuticals, pest-resistant crops and biofuels, among other products. Revenue for the industry has grown over the past five years and global investment in biotechnology has increased consistently, with much of the added R&D spending funneled into medical applications aimed at providing care for the aging global population. The industry is expected to continue prospering over the next five years, with the Asia-Pacific region making significant investments to gain a foothold in the market. Larger players will increasingly pursue low-risk growth strategies, such as partnering with academic institutions and acquiring smaller firms with products already in the late stages of development.
Firms in this industry primarily use living organisms or molecular and cellular techniques to develop products that are used in agriculture, food, industrial and medicine production.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.